Inovio Pharmaceuticals, Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of Weiner David B.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Weiner David B. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:INO / Inovio Pharmaceuticals, Inc. Director 86,620
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Weiner David B.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases INO / Inovio Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in INO / Inovio Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INO / Inovio Pharmaceuticals, Inc. Insider Trades
Insider Sales INO / Inovio Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in INO / Inovio Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2018-04-16 INO Weiner David B. 9,000 4.9114 750 58.9368 44,203 326 40.08 -14,142 -31.99
2017-05-25 INO Weiner David B. 8,000 8.0020 667 96.0240 64,016

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INO / Inovio Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Weiner David B. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-21 2025-05-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,167 86,620 2.57
2025-02-28 2025-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 972 84,453 1.16
2025-02-28 2025-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 972 84,453 1.16
2024-05-16 2024-05-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,166 82,509 2.70
2024-02-28 2024-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 972 80,343 1.22
2024-02-28 2024-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 972 80,343 1.22
2024-02-28 2024-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 972 79,371 1.24
2023-05-16 2023-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 19,000 929,124 2.09
2023-03-13 2023-03-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,833 910,124 -0.64 1.15 -6,708 1,046,643
2023-03-13 2023-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,666 915,957 1.29
2023-02-28 2023-02-27 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11,668 904,291 -1.27 1.28 -14,935 1,157,492
2023-02-28 2023-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 915,959 1.29
2023-02-28 2023-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 915,959 1.29
2022-08-11 2022-08-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11,875 892,625 -1.31 2.66 -31,588 2,374,382
2022-08-11 2022-08-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,875 904,500 1.33 2.16 25,650 1,953,720
2022-05-17 2022-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 28,000 28,000
2022-05-17 2022-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 19,000 19,000
2022-05-17 2022-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9,000 892,625 -1.00 1.95 -17,550 1,740,619
2022-05-17 2022-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -18,000 0 -100.00
2022-05-17 2022-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 18,000 901,625 2.04
2022-03-14 2022-03-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,083 883,625 -0.46 3.20 -13,066 2,827,600
2022-03-14 2022-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,667 11,666 -50.00
2022-03-14 2022-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 887,708 1.33
2022-03-09 2022-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,083 876,041 -0.46 3.33 -13,596 2,917,217
2022-03-09 2022-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,666 0 -100.00
2022-03-09 2022-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,666 880,124 1.34
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 35,000 35,000
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 60,000 60,000
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,667 23,333 -33.33
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 868,458 1.36
2021-05-17 2021-05-17 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,045 856,791 -0.35 6.62 -20,158 5,671,956
2021-05-17 2021-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,700 0 -100.00
2021-05-17 2021-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,700 859,836 1.02
2021-05-17 2021-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 18,000 18,000
2021-05-17 2021-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 27,000 27,000
2021-04-21 2021-04-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -22,500 0 -100.00
2021-04-21 2021-04-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,083 851,136 -0.48 8.54 -34,869 7,268,701
2021-04-21 2021-04-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -22,500 855,219 -2.56 8.57 -192,825 7,329,227
2021-04-21 2021-04-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 22,500 877,719 2.63 2.40 54,000 2,106,526
2021-03-12 2021-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,667 23,333 -33.33
2021-03-12 2021-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 855,219 1.38
2021-03-09 2021-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,500 843,552 -0.41 9.60 -33,601 8,098,352
2021-03-09 2021-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,667 11,666 -50.00
2021-03-09 2021-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 847,052 1.40
2021-03-09 2021-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,500 835,385 -0.42 9.18 -32,135 7,670,004
2021-03-09 2021-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,666 0 -100.00
2021-03-09 2021-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,666 838,885 1.41
2021-02-26 2021-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 35,000 35,000
2021-02-26 2021-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 60,000 60,000
2020-12-17 2020-12-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -17,500 0 -100.00
2020-12-17 2020-12-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -17,500 827,219 -2.07 10.71 -187,352 8,856,041
2020-12-17 2020-12-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 17,500 844,719 2.12 4.56 79,800 3,851,919
2020-05-15 2020-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 8,700 8,700
2020-05-15 2020-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 13,300 13,300
2020-05-12 2020-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,404 827,219 -0.29 11.84 -28,463 9,794,273
2020-05-08 2020-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,013 0 -100.00
2020-05-08 2020-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,013 829,623 0.98
2020-03-12 2020-03-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,500 821,610 -0.42 11.14 -38,990 9,152,735
2020-03-12 2020-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 60,000 60,000
2020-03-12 2020-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 35,000 35,000
2020-03-12 2020-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,666 0 -100.00
2020-03-12 2020-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,500 825,110 -0.42 9.32 -32,620 7,690,025
2020-03-12 2020-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,666 828,610 1.43
2020-03-09 2020-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,500 816,944 -0.43 18.00 -63,000 14,704,992
2020-03-09 2020-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,667 23,333 -33.33
2020-03-09 2020-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 820,444 1.44
2020-03-09 2020-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,667 11,666 -50.00
2020-03-09 2020-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 808,777 1.46
2019-08-02 2019-08-01 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16,352 797,110 -2.01 2.72 -44,477 2,168,139
2019-05-13 2019-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,170 0 -100.00
2019-05-13 2019-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,170 813,462 1.01
2019-05-09 2019-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 8,013 8,013
2019-05-09 2019-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 12,500 12,500
2019-03-12 2019-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,667 11,666 -50.00
2019-03-12 2019-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 805,292 1.47
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -10,000 0 -100.00
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -5,333 0 -100.00
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 793,625 1.28
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,333 783,625 0.69
2019-03-12 2019-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 35,000 35,000
2019-03-12 2019-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 60,000 60,000
2019-03-07 2019-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,667 23,333 -33.33
2019-03-07 2019-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 778,292 1.52
2018-05-14 2018-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -7,669 0 -100.00
2018-05-14 2018-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7,669 766,625 1.01
2018-05-14 2018-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 8,170 8,170
2018-05-14 2018-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 12,500 12,500
2018-04-19 2018-04-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -9,000 758,956 -1.17 4.91 -44,203 3,727,536
2018-03-14 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 35,000 35,000
2018-03-14 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 60,000 60,000
2018-03-13 2018-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -11,667 23,333 -33.33
2018-03-13 2018-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,667 767,956 1.54
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -5,333 5,333 -50.00
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -10,000 10,000 -50.00
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,333 756,289 0.71
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 750,956 1.35
2017-05-26 2017-05-25 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -8,000 740,956 -1.07 8.00 -64,016 5,929,130
2017-05-15 2017-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -10,000 0 -100.00
2017-05-15 2017-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 748,956 1.35
2017-05-15 2017-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 12,500 12,500
2017-05-15 2017-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 7,669 7,669
2017-03-13 2017-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 35,000 35,000
2017-03-13 2017-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 60,000 60,000 6.68 400,800 400,800
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -10,000 20,000 -33.33
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -5,334 10,666 -33.34
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 738,956 1.37
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,334 728,956 0.74
2016-06-06 2016-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 10,000 10,000 9.33 93,300 93,300
2016-06-06 2016-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 10,000 10,000
2016-03-11 2016-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 30,000 30,000
2016-03-11 2016-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 16,000 16,000
2016-03-11 2016-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 30,000 30,000 7.02 210,600 210,600
2016-03-11 2016-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 16,000 16,000 7.02 112,320 112,320
2016-03-11 3 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
1,447,244
2016-03-11 3 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
1,447,244
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)